Johnson & Johnson’s Abiomed has sent an urgent medical device correction about a malfunction risk linked to 22 reports of ...
The Food and Drug Administration Feb. 3 released an early alert on a heart pump issue from certain Abiomed products.
The FDA has issued an early alert warning of a potentially high-risk issue affecting certain Abiomed heart pumps. The agency said Abiomed issued an urgent medical device correction Jan. 27 for all ...
The agency says there have been 22 injuries and no deaths associated with this potentially high-risk device issue.
The brand's newest power bank and solar panel are designed for expansion to fit your exact needs during an outage.